Ashley E. Ross, M.D., PhD
Bethesda, Md., (March 27, 2014) – Suburban Hospital hosts the Prostate Cancer Survivorship Series presentation, “New Advances in Molecular Testing for the Guidance of Patients Considering Active Surveillance,” on Wednesday, April 30, 2014, from 7:00-8:15 pm in the hospital auditorium, located at 8600 Old Georgetown Road in Bethesda.
Prostate cancer can be potentially lethal, but it can also have a slow disease course, as nearly half of all newly diagnosed men may end up not needing immediate treatment.
Join Ashley E. Ross, M.D., PhD, assistant professor, Departments of Urology, Oncology and Pathology, Johns Hopkins School of Medicine, for a discussion about emerging tests that use molecular features of prostate cancer to better determine which patients require immediate treatment and which may be good candidates for surveillance.
To register for this free event, visit suburbanhospital.org/events or call 301-896-3939. For more information, contact Pam Goetz at 202-243-2320 or email@example.com.
About Suburban Hospital
Suburban Hospital, a member of Johns Hopkins Medicine, is a not-for-profit, community-based hospital in Bethesda, Maryland, that has served Montgomery County and Northwest DC for more than 70 years. Suburban Hospital is distinguished by a cutting-edge stroke program; level II trauma center; centers of excellence in cardiac care, orthopedics and joint replacement surgery, neurosciences and oncology; state-of-the-art diagnostic and treatment tools; and affiliations with major health care organizations like the neighboring National Institutes of Health. For more information, find us on Facebook or visit suburbanhospital.org.